Stock Ratings / Industrials / NUR / financials

JBDI (45) IDXG (66) BHST (34) RML (58) ⌘ Pro Terminal →

Nuran Wireless Inc. (NUR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Q: How profitable is Nuran Wireless Inc. (NUR)?

In Trailing 12 Months, NUR converted $4.0B of revenue into a 52% gross margin, 27% operating margin, and $251264 in free cash flow (0% FCF margin).

$0.68 +0.95% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.68

Nuran Wireless Inc. (NUR) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $9.0M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.68 (-0.02%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NUR)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (58/100 Composite)

🔍 WHY NUR SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (24% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$0.77-5.2% Next Q

Q2 (-2Q)

Grade C+$0.73+1.4% Next Q

Q3 (-1Q)

Grade C$0.74-8.1% Next Q

Current

Grade D+$0.68+0% Hist 90D α

Trajectory: B- (66) → D+ (58)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the NUR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 58/100 (D+) score, NUR faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($1.21) or 200D SMA ($1.60) invalidates the momentum regime and cuts Target Base ($0.68) toward Bear Floor ($0.53).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NUR• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NUR Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 58%NO 42%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • Trailing 12 Months

How NUR Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$251.3K (0% FCF Margin)

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NUR)

✓Walkthrough of NUR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NUR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -83.65%▲ RESISTANCE BREAKOUT

2026-10-30O $0.67H $0.80L $0.64C $0.68VOL 1.22M

RES: $0.45SUP: $0.27SMA50: $1.21SMA200: $1.60

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NUR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NUR Butterfly Map → + Track NUR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NUR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NUR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NUR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NUR)

Industrials Rank #209 of 485 ⚔️ JBDI vs NUR Full Matrix →

1. Head-to-Head Industrials Peer Comparison (NUR vs. JBDI, IDXG, BHST, RML)

Industry: Diversified Equities (43 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Nuran Wireless Inc. (NUR) ranks #209 by composite RQD confidence (58/100, grade D+) and #454 by equity capitalization ($9.0M). Within this direct 5-issuer industry benchmark cohort, NUR leads on earnings valuation at N/A trailing P/E, while IDXG leads on capital efficiency and profitability with 16.2% ROIC and 62.3% gross margin. IDXG currently holds the highest overall quantitative score in the immediate peer group at 66/100 (C+) compared with NUR at 58/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NUR ACTIVE Nuran Wireless Inc.	D+	58/100	—	—	—	+0.95%	$9.0M	Benchmark Subject
JBDI JBDI Holdings Limited	D	45/100	—	49.9%	—	+0.42%	$22.9M	/jbdi-vs-nur →
IDXG Interpace Biosciences Inc.	C+	66/100	—	62.3%	16.2%	+15.56%	$23.2M	/idxg-vs-nur →
BHST BioHarvest Sciences Inc.	E	34/100	—	59.3%	-35.0%	-5.68%	$37.6M	/bhst-vs-nur →
RML Resolution Minerals Ltd	D+	58/100	—	—	—	-1.99%	$44.1M	/rml-vs-nur →

2. NUR Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Nuran Wireless Inc. (NUR) operates in Diversified Equities (Industrials) with an equity capitalization of $9.0M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. NUR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NUR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Nuran Wireless Inc. (NASDAQ: NUR) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $0.68 (+0.95% 1D, market cap $9.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 485 tracked Industrials issuers, NUR ranks #209 in composite RQD confidence.

How does NUR compare to JBDI and IDXG in the Industrials sector?

Within the Industrials sector (Diversified Equities), NUR carries a Roarable D+ (58/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, JBDI (JBDI Holdings Limited) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $22.9M) and IDXG (Interpace Biosciences Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 16.2%, cap $23.2M). Among the 5-stock peer group, NUR leads on earnings multiple (N/A) while IDXG leads on capital efficiency (16.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NUR?

For Nuran Wireless Inc. (NUR), key quantitative strengths include Established market leader in Industrials with deep daily trading liquidity. and sector rank #209 in Industrials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NUR trading relative to its 50-day, 200-day, and 52-week technical levels?

NUR last traded at $0.68 (+0.95% on volume of 29,819,045 shares), positioning the stock -43.80% below its 50-day simple moving average ($1.21) and -57.50% below its 200-day simple moving average ($1.60). Across its 52-week range of $0.53 to $7.72, NUR sits at the 2.1% percentile with a 14-day RSI of 31.8 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.77).

NUR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Nuran Wireless Inc. (NUR)?

In Trailing 12 Months, NUR converted $4.0B of revenue into a 52% gross margin, 27% operating margin, and $251264 in free cash flow (0% FCF margin).

Direct Sub-Reports: NUR RQD Cockpit NUR 12M Forecast NUR Earnings & Move NUR Dividends & DRIP NUR Insiders & 13F NUR Whale Options NUR Profit Sankey NUR News & Why